14-day Premium Trial Subscription Try For FreeTry Free

Range Low Price High Price Comment
30 days $0.727 $1.10 Friday, 3rd May 2024 ALGS stock ended at $0.81. This is 4.24% less than the trading day before Thursday, 2nd May 2024. During the day the stock fluctuated 7.59% from a day low at $0.790 to a day high of $0.85.
90 days $0.620 $1.20
52 weeks $0.540 $1.34

Historical Aligos Therapeutics Inc. prices

Date Open High Low Close Volume
May 03, 2024 $0.83 $0.85 $0.790 $0.81 185 308
May 02, 2024 $0.752 $0.87 $0.752 $0.85 326 243
May 01, 2024 $0.750 $0.790 $0.750 $0.770 84 256
Apr 30, 2024 $0.742 $0.789 $0.740 $0.765 181 038
Apr 29, 2024 $0.782 $0.80 $0.727 $0.734 136 356
Apr 26, 2024 $0.82 $0.83 $0.770 $0.782 110 399
Apr 25, 2024 $0.81 $0.83 $0.782 $0.82 129 863
Apr 24, 2024 $0.82 $0.87 $0.790 $0.83 644 248
Apr 23, 2024 $0.80 $0.90 $0.80 $0.82 96 855
Apr 22, 2024 $0.772 $0.81 $0.740 $0.80 467 149
Apr 19, 2024 $0.770 $0.80 $0.730 $0.750 139 291
Apr 18, 2024 $0.789 $0.83 $0.758 $0.793 239 212
Apr 17, 2024 $0.81 $0.83 $0.787 $0.787 121 391
Apr 16, 2024 $0.89 $0.91 $0.80 $0.84 247 233
Apr 15, 2024 $1.01 $1.01 $0.87 $0.89 327 451
Apr 12, 2024 $1.05 $1.08 $1.00 $1.00 293 101
Apr 11, 2024 $1.02 $1.09 $1.02 $1.06 356 580
Apr 10, 2024 $1.05 $1.08 $0.99 $1.04 347 862
Apr 09, 2024 $1.03 $1.10 $1.03 $1.06 237 400
Apr 08, 2024 $1.02 $1.09 $1.02 $1.07 336 768
Apr 05, 2024 $0.99 $1.04 $0.97 $1.04 289 668
Apr 04, 2024 $1.00 $1.02 $0.96 $0.97 356 994
Apr 03, 2024 $1.00 $1.04 $0.98 $1.01 407 571
Apr 02, 2024 $0.92 $1.00 $0.92 $0.98 324 547
Apr 01, 2024 $0.99 $1.04 $0.95 $0.95 667 082
Click to get the best stock tips daily for free!

About Aligos Therapeutics Inc.

Aligos Therapeutics. Aligos Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses to develop novel therapeutics to address unmet medical needs in viral and liver diseases. Its lead drug candidate is ALG-010133, a s-antigen transport-inhibiting oligonucleotide polymer that is in Phase Ib clinical trial for the treatment of chronic hepatitis B (CHB); and ALG-000184, a capsid assembly modulator, which is in Phase I clinical trials to treat CHB. The com... ALGS Profile

Top Fintech Company

StockInvest.us featured in The Global Fintech Index 2020 as the top Fintech company of the country.

Full report by FINDEXABLE

ROCKIT